Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Imugene Ltd (OP:IUGNF)

0.0184 -0.0006 (-3.16%)
Streaming Delayed Price Updated: 3:26 PM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Imugene Ltd

Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company is preparing 10 clinical trial sites in Australia and the UK for a new PD1-Vaxx Phase 2 colorectal (CRC) cancer clinical... 
Via TheNewswire.com
Imugene to commence new phase 2 PD1-Vaxx bowel cancer trial
--News Direct-- 
Via News Direct
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong and chief medical officer Dr Paul Woodard speak with Proactive following the news it’s been granted 'Fast Track' designation from the US Food and Drug... 
Via TheNewswire.com
Exposures Product Safety
Imugene thrilled as VAXINIA granted FDA Fast Track designation
--News Direct-- 
Via News Direct
Exposures Product Safety
Imugene thrilled as first patient dosed in Phase 1 OASIS trial
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive the company has marked a milestone with the start of its Phase 1 clinical trial for onCARlytics, a CD19 oncolytic virotherapy drug... 
Via TheNewswire.com
Imugene thrilled as first patient dosed in Phase 1 OASIS trial
--News Direct-- 
Via News Direct
Imugene talks VAXINIA MAST trial and corporate ambition
--News Direct-- 
Via News Direct
Imugene talks VAXINIA MAST trial and corporate ambition
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong speaks with Proactive soon after the company announced it has cleared the first cohort of patients of the intratumoral (IT) arm of its VAXINIA... 
Via TheNewswire.com
Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
Imugene Ltd (ASX:IMU, OTC:IUGNF) CEO Leslie Chong tells Proactive it has been a busy and productive start to the new year with a number of presentations including at the JP Morgan Healthcare... 
Via TheNewswire.com
Imugene off to strong start to 2023 with JP Morgan Healthcare Conference
Imugene off to strong start to 2023 with JP Morgan Healthcare Conference 
Via News Direct
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.